BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

AZEVAN PHARMACEUTICALS, INC. — Lobbying — Receipts Report

LD-2 disclosure · Registration

AZEVAN PHARMACEUTICALS, INC.

via K&L GATES, LLP

1st Quarter (Jan 1 - Mar 31) · 2010Posted Mar 25, 2010Filing document ↗LDA record ↗

Coverage · Registration filing — establishes the registrant/client relationship. No periodic income or expenses are reported at registration.

Client

Name: AZEVAN PHARMACEUTICALS, INC.
Description: Research and development of specialty neurological pharmaceuticals.
Location: Pennsylvania · United States of America

Registrant

Firm: K&L GATES, LLP
Description: Law firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

2 issues

Budget/Appropriations
Seeking Congressional funding for FY 2011 Department of Defense Appropriations for client medical R&D work..
LobbyistsSLADE GORTON · PETER GLEASON · W DENNIS STEPHENS · NICHOLAS LEIBHAM · STEVEN MCCAIN
Defense
Seeking Congressional funding for FY 2011 Department of Defense Appropriations for client medical R&D work..
LobbyistsSLADE GORTON · PETER GLEASON · W DENNIS STEPHENS · NICHOLAS LEIBHAM · STEVEN MCCAIN

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.